Fujimoto 2010.
Methods | |
Participants | People with non‐cardioembolic ischaemic stroke within 72 hours of the onset and NIHSS score ≤ 7 |
Interventions | Cilostazol (200 mg/d) plus intravenous antithrombotic agents (heparin, ozagrel sodium or argatroban) versus intravenous antithrombotic agents (heparin, ozagrel sodium or argatroban) |
Outcomes | Neurological deterioration and stroke recurrence at 14 days, and mRS at 3 months |
Notes |